Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longidaza + Metronidazole for Recurrent Bacterial Vaginosis
NCT06458543Phase 4Recruiting
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Polymer-based Nanoparticles, Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of bovhyaluronidase azoximer in bacterial vaginosis (BV), sponsored by Sechenov First Moscow State Medical University. Started Jun 2024; status: recruiting.
02
Drugs
bovhyaluronidase azoximer
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT06458543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06458543.